Somatostatin Receptor Ligand device attribute survey
Somatostatin Receptor Ligand device attribute survey
Prof. Dr. Jeroen Dekervel, Prof. Dr. Ángel Cequier Fillat, Dr Jose Santos, Prof. Maria Luisa Brandi
A survey to identify the key Somatostatin Receptor Ligand (SRL) device attributes that lead to the best injection experience in people living with acromegaly and NET, as well as those caring for them. The HCP and patient/caregiver surveys have been developed by a Scientific Committee comprising Endocrinologists, Nurses and Patient Advocates from the World Alliance of Pituitary Organizations (WAPO) and the International Neuroendocrine Cancer Alliance (INCA).
We are seeking responses from people living with acromegaly and NET, caregivers, nurses and physicians in Denmark, Norway, Spain and the USA.
Prof. Dr. Jeroen Dekervel
GI Oncologist
UZ Leuven
Belgium
Prof. Dr. Ángel Cequier Fillat
Cardiologist
University of Barcelona
Spain
Dr Jose Santos
123456789012345678901234567890123456789012345678901234567890
123456789012345678901234567890123456789012345678901234567890
Spain
Prof. Maria Luisa Brandi
Endocrinologist
FIRMO Foundation, Florence
Italy
Media YouTube
Survey | 
22 min
|
Jul 2022
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
SCORM Example
Survey | 60 min
|
Jul 2022
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
This educational programme is supported by an Independent Medical Education Grant from This programme is supported by an Independent Educational Grant from Bayer
Other programmes of interest
0 min
Other programmes developed by Prof. Dr. Ángel Cequier Fillat
Prof. Dr. Ángel Cequier Fillat
Cardiologist
University of Barcelona
Spain
